Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
The clinical evaluation of childhood movement disorders depends on the crucial step of phenomenology that precedes and guides evaluation and management. Historically, many of the chronic movement disorders were identified as phenotypic syndromes based on clinical presentation, associated symptoms, and disease course. With the growing availability of genetic testing, more of the underlying metabolic and heredodegenerative disorders causing chronic movement disorders are being identified, producing a clearer understanding of the full clinical spectrum of these disorders ( Fig. 40.1 ).
Movement disorders are a group of disorders where there is excessive movement or a paucity of voluntary movement ( Table 40.1 ). The problem is not primarily due to weakness or abnormality of tone (spasticity). This group of disorders is characterized by difficulty initiating movement, abnormal control of voluntary movement, abnormalities of posture, or the presence of unwanted involuntary movements. Primary movement disorders imply a dysfunction in the basal ganglia and its connections or dysfunction of the cerebellum and its connections.
|
Movements disorders in general can be divided into two main categories. There may be a paucity of normal voluntary movements ( hypokinetic ) or the presence of abnormal involuntary movements ( hyperkinetic ). The hyperkinetic movement disorders include dystonia, ataxia, tremor, chorea, athetosis, ballismus, tics, and myoclonus. In the hypokinetic disorders there is a paucity or decreased amplitude of normal voluntary movements (hypokinesia), slow voluntary movements or difficulty initiating voluntary movement (bradykinesia), or loss of movement (akinesia). One example of a hypokinetic movement disorder is parkinsonism (resting tremor, slow voluntary movements, rigidity).
The presenting symptom or chief complaint in a child with a movement disorder may be any of the following:
Inability to sit still
Gait abnormality
Twitching
“Weakness” or dropping things
Shaking/trembling of the hands
Unsteadiness
Abnormal movements
The goal of the history and examination is to confirm the presence of the abnormal movement and correctly characterize it. Phenomenology is the study or observation of the abnormality. The clinical evaluation of movement disorders emphasizes the question “What type of abnormal movement is present?” or “What is the phenomenology?” rather than “Where is the lesion in the neurologic axis?” Phenomenology is determined by clinical examination, observation, and, when necessary, videotape review. Videotape review is especially useful when a paroxysmal movement is not witnessed during the clinic visit. Phenomenology links directly to potential differential diagnosis as well as choice of symptomatic therapy.
The clinical history in the child with a suspected movement disorder should include the course of the problem, whether acute or chronic. Specific information on whether the movements are paroxysmal (episodic) should be obtained. If the abnormal movements are paroxysmal, the history should indicate whether the abnormal movements are task specific (e.g., writer’s cramp, which is a task-specific focal dystonia) and whether there are specific triggers that provoke the abnormal movements. Initiation of sudden movement that triggers dystonia is the hallmark of paroxysmal kinesigenic dystonia or dyskinesia ( Table 40.2 ). Anticipation, emotional change, and stress can increase the frequency of tics. Excitement and emotional distress tend to bring out stereotypies. In general, abnormal movements do not awaken a child from sleep. Most movement disorders disappear in deep sleep except for ballismus and severe torsion dystonia. An abnormal movement that awakens a child from sleep should raise the suspicion for seizures.
PKD | PNKD | PED | PHD ∗ | |
---|---|---|---|---|
Inheritance | AD | AD | AD | Usually sporadic |
Gender M:F | 4:1 | 2:1 | 2:3 | 7:3 |
Age at onset, yr | <1–20 | <1–20s | 2–30 | 4–20s |
Phenomenology of abnormal movements | Dystonia with or without chorea/ballism, uni- or bilateral | Dystonia with or without choreoathetosis, uni- or bilateral, rarely spasticity | Dystonia, sometimes in combination with choreoathetosis, uni- or bilateral | Dystonia, chorea, ballism |
Triggers | Sudden movement, change in direction, acceleration, startle | Alcohol, caffeine, emotions, fatigue | Prolonged exercise, muscle vibration | Sleep |
Duration of paroxysms | Seconds up to 5 min | 2 min–4 hr | 5 min–2 hr | 30 min up to 50 min |
Frequency of paroxysms | 1 per month to 100 per day | Few per week to few in a lifetime | Few per month | Few per year to few per night |
Genetics |
|
|
|
|
Treatment | Anticonvulsants (carbamazepine, phenytoin, others) | Avoiding triggers, benzodiazepines (clonazepam) | Avoiding triggers, ketogenic diet (in GLUT-1 deficiency) | Anticonvulsants |
∗ Also known as autosomal dominant nocturnal frontal lobe epilepsy.
The history should clarify the areas of the body affected, severity, and degree of functional impairment. Associated neurologic symptoms such as weakness, visual disturbance, seizures, and mental status changes imply a more widespread neurologic process than that primarily affecting the basal ganglia. Symptoms such as fever, rash, and pharyngitis suggest the presence of systemic illness.
The impact of the abnormal movement on the child’s day-to-day function as well as limitations of function should be documented.
A detailed academic, behavioral, and psychiatric history should be obtained as movement disorders are often accompanied by behavioral, emotional, cognitive, and psychiatric comorbidities.
The history should include medications that have been recently started or stopped as well as chronic medications.
The child’s birth and developmental history clarify whether the movement disorder occurred in a child who had no preceding neurologic conditions or in a child who had prior neurologic/developmental difficulty. The age of onset may provide a clue to the diagnosis ( Fig. 40.2 and Table 40.3 ).
Prenatal | Neonatal | Infancy and Childhood | Adolescence and Adulthood |
---|---|---|---|
|
|
|
|
Family history of similar symptoms or a variation of the same type of problem suggests a genetically inherited disorder.
The general physical examination should determine the presence of systemic signs.
The comprehensive neurologic examination determines whether there are other neurologic abnormalities besides involuntary movements. The mental status examination should include observations about alertness, attention, behavior, mood, and emotions. Cranial nerve examination should specifically determine whether there is nystagmus, limitation of eye movements, or weakness of the face, tongue, and jaw muscles. In general, the motor exam portion of the neurologic examination tends to emphasize muscle tone, strength, and the muscle stretch reflexes (deep tendon reflexes). This portion of the motor exam is effective in identifying the presence of weakness, spasticity, or hypotonia. Some features of involuntary movements such as the inability to maintain a voluntary contraction may be detected during the general motor examination. The template of the motor examination that starts with muscle tone, then goes on to testing of strength, and ends with reflex testing is useful for localization but insufficient for characterization of abnormal movements. Although it is assumed that general observation of the patient occurs throughout the visit, this alone is often insufficient for accurate characterization of the movement disorder. Therefore, once the motor exam that assesses tone, strength, and reflexes is completed, an additional portion of time should be allocated specifically for the observation of the involuntary movements to categorize them (phenomenology).
Posture and abnormal movements should be observed while the patient is in the recumbent position, in the seated position, standing upright with arms by the side, and then standing with arms and fingers outstretched. The child’s ability to maintain a voluntary posture or voluntary muscle contraction should be assessed. This includes the ability to maintain grip while holding the examiner’s hands and the ability to maintain tongue protrusion. Observation of tasks such as picking up, grasping, playing with small toys, pouring water from glass to glass, and writing is useful in the characterization of involuntary movements affecting the upper extremities, trunk, and neck. Stance, gait, swivel, running, stooping, and recovering should be assessed. Observation of speech is important as abnormal movements of the tongue, palate, lower face, and jaw affect the quality of speech. Abnormal movements of the laryngeal muscles affect voice production and quality. Motor impersistence and parakinesia (described in the section on chorea) should be recognized and identified when present. Paroxysmal movements such as tics may be briefly suppressible during a voluntary motor task, only to emerge once the task is accomplished. Tics when mild may not be witnessed in the clinic. Paroxysmal kinesigenic dystonia is often provoked by getting up from the seated position or at the beginning of a short sprint (see Table 40.2 ). Paroxysmal movements that occur between periods of normalcy may not be witnessed during the examination. When a paroxysmal movement is not witnessed in the clinic, videotape review is often helpful.
The gait examination is an essential component of the neurologic examination in a child with a movement disorder. The various gait abnormalities linked to the different movement disorders are listed in Table 40.4 .
Ataxia | Wide-based stance. Extra steps to the side or backward to maintain balance while standing still. Extra steps to the side and a “drunken”-type gait with trunk sway when walking. Veering to the side and falls especially when turning or changing direction. Hurls self forward while running with a tendency to fall at the end of the run. In general, the mildly ataxic child tends to have a harder time standing still or walking slowly compared to running. When severe, standing, walking, and running are all significantly impaired. |
Choreoathetosis | Lurching-type gait. Difficulty standing still or motionless with intermittent, random jerky movements of arms, neck, trunk, legs, and face giving rise to a “fidgety” appearance. |
Tics | Normal gait and coordination. |
Stereotypies | Normal gait. |
Dystonia | If dystonia is focal and does not involve the legs or trunk, gait may be normal. In generalized dystonia, look for twisting and/or prominent lordosis of the trunk or twisting inward or medially of the legs. The feet may be inverted and plantarflexed. The abnormality tends to become more noticeable the longer the patient walks or runs. When dystonia is severe, the affected limbs tend to move “en bloc” with little apparent flexibility at the joints. |
Tremor | Gait can be normal. In the parkinsonian patient there is difficulty initiating movement and the gait is often slow and “stiff.” In the patient with orthostatic tremor, standing brings out the tremor in the legs. The tremor disappears or improves when seated or walking. |
Myoclonus | Gait is usually normal. If myoclonus affects the trunk or legs, lightning-like jerks depending on the amplitude can result in falls. |
Dystonia is defined as a movement disorder in which involuntary sustained or intermittent muscle contractions cause twisting and repetitive movements, abnormal postures, or both. Dystonia is often initiated or worsened by voluntary action and associated with overflow muscle activation.
Dystonia can affect any part of the body. Terms used to describe the distribution of dystonia include focal, segmental, multifocal, and generalized. Focal dystonia affects a single body part. Examples of focal dystonia include blepharospasm (involuntary spasms of the eyelids), torticollis (dystonia of the neck muscles), and writer’s cramp (dystonia of the hand). Dystonia that affects two contiguous body parts is referred to as segmental dystonia (e.g., neck and arm or face and arm). Dystonia of two noncontiguous body parts is referred to as multifocal dystonia. Dystonia on one side of the body (e.g., left leg and left arm) is described as hemidystonia. Dystonia of more than one limb with involvement of the trunk is termed generalized dystonia. Dystonia may affect the larynx in isolation as a focal dystonia or as part of a more generalized dystonia giving rise to a “strangled,” “whispery,” or “breathy” quality of voice production. The distribution of dystonia may be sometimes helpful in localization. For example, acute hemidystonia may be due to pathology in the contralateral basal ganglia. The documentation of the distribution of dystonia also helps in the clinical detection of progression of disease over time.
The clinical evaluation of a patient with dystonia should delineate the time course of symptoms (acute, subacute, or chronic), distribution, whether it is present all the time or paroxysmal (if paroxysmal, whether it is provoked by initiation of movement), whether there is a diurnal variation (worse toward the end of the day), presence of other symptoms, and family history of similar conditions.
The etiology or underlying causes of pediatric dystonia are quite heterogenous. It is helpful in the clinical setting to differentiate acute dystonia from subacute or chronic dystonia. Acute dystonia in general suggests that the dysfunction in the brain is acute and therefore should be evaluated urgently. Associated symptoms of fever or systemic symptoms suggest a primary central nervous system (CNS) infection or inflammation that requires urgent evaluation.
Subacute and chronic dystonia are usually due to more slowly progressive acquired conditions, genetic disorders, or heredodegenerative conditions.
When faced with a child presenting with acute dystonia, the evaluation should be conducted rapidly considering drugs/toxins, infection, inflammation, and acute ischemia as possible causes ( Table 40.5 ).
|
In these situations, dystonia is often not isolated and is often accompanied by systemic symptoms and signs or other abnormalities in the neurologic system such as mental status changes, seizures, or acute psychiatric symptoms.
Viral or bacterial encephalitis may affect the basal ganglia, giving rise to an acute movement disorder with dystonia, usually in the setting of systemic symptoms and symptoms arising from multifocal involvement of the brain.
Postinfectious syndromes such as acute disseminated encephalomyelitis (ADEM) may present with a mixed movement disorder with dystonia.
N -methyl- d -aspartate receptor (NMDAR antibody) encephalitis is one of the more well-defined autoimmune disorders presenting with both movement disorders (chorea, dystonia) and neuropsychiatric symptoms. The symptoms usually evolve in a subacute to chronic fashion occasionally with acute worsening. A clinical suspicion of the condition, often with MRI signal changes in the hippocampi, mesial temporal lobes, thalamus, and brainstem (not all cases have MRI changes), with NMDAR antibody positivity in serum and cerebrospinal fluid (CSF) help clinch the diagnosis. Screening for an underlying tumor should be undertaken. Cases in children and adolescents have been linked to ovarian or testicular teratoma, seminoma, and small-cell lung cancer. The incidence of tumors in children with this condition is lower than that of adults. Management is with immune therapy following tumor resection (in the cases linked to tumors).
Areas affected include the jaw muscles (trismus), neck (torticollis), back (opisthotonus), and extraocular muscles (oculogyric deviation of eyes). The patient may also have trouble chewing or swallowing. Although these sudden movements can mimic seizures, the patient remains fully aware of their surroundings and the dystonia resolves almost immediately with intravenous Benadryl. Commonly used medications such as antiemetics, anticonvulsants, and neuroleptics with dopamine-blocking properties can give rise to acute or delayed dystonic reactions.
Paroxysmal dystonia in sleep should raise the suspicion of seizures and appropriate neurophysiologic evaluation may be needed to differentiate seizures from a movement disorder. Paroxysmal dystonic movements with alteration of consciousness should also raise the suspicion of seizures ( Table 40.6 ).
|
Paroxysmal dystonia or choreoathetosis triggered by the initiation of movement suggests the diagnosis of paroxysmal kinesigenic dyskinesia (PKD) (see Table 40.2 ). PKD appears to be a heterogenous disorder in which initiation of movement triggers episodes of dystonia or choreoathetoid movements. The symptoms are often unilateral. Onset of symptoms is between ages 1 and 20 years. The episodes of dystonia are clinically distinct from seizures because consciousness is fully preserved, and the episodes are triggered by the initiation of movement. There is no associated pain with these episodes. The episodes last seconds to less than a minute. Some patients have additional neurologic disorders such as benign infantile epilepsy. Infantile convulsions followed by PKD in late childhood or adolescence is thought to be a variant form of PKD.
The diagnosis of PKD is confirmed by the absence of organic disease or structural abnormality on neuroimaging and the response to anticonvulsant medications such as carbamazepine, usually in low doses. This condition may be sporadic or familial. Familial PKD can be caused by variants in the proline-rich transmembrane protein 2 ( PRRT2 ). However, this gene is found in only a portion of individuals with PKD. Variants in KCNA1 are identified in some families with PKD. A diagnostic approach to paroxysmal dyskinesias is noted in Fig. 40.3 .
Episodic arching or dystonic posture of the neck and back in an infant or child can be seen in the setting of reflux. These episodes are usually related to feeds.
This is thought to be a migraine variant. In this condition children have paroxysmal episodes of head and/or trunk tilt that can last for hours or days, usually without other symptoms. Onset can be as early as the first year of life. Usually these episodes gradually decrease with age and resolve or evolve into episodes of migraine as the child grows older. At initial presentation, a detailed clinical evaluation should be undertaken, with appropriate testing to rule out organic causes. Careful monitoring should occur to determine whether these symptoms evolve into those of migraine or change to suggest a chronic neurogenetic dystonia that would warrant further evaluation.
Alternating hemiplegia of childhood (AHC) is a rare condition presenting in childhood with episodes of temporary paralysis, often affecting one side of the body (hemiplegia). The episodes usually occur before age 18 months and last from minutes to days. Although not primarily a movement disorder, individuals can also have episodic choreoathetosis or dystonia in addition to episodes of hemiplegia. The episodes of abnormal movements can occur during or separate from the episodes of paralysis. These episodes can occur with triggers of stress, cold, or extreme tiredness. Sometimes there is no recognizable trigger. Other potential symptoms include developmental delay, abnormal eye movements, and seizures. Most individuals have pathogenic variants in ATP1A3, and a smaller number have variants in ATP1A2 . There is a high rate of de novo (sporadic) events, so many patients do not have a family history of similar symptoms. When there is a family history, it tends to follow an autosomal dominant pattern. Several treatments have been used including flunarizine, benzodiazepines, topiramate, oral adenosine triphosphate (ATP), coenzyme Q, acetazolamide, aripiprazole, and dextromethorphan, with various rates of success in aborting attacks or decreasing their frequency.
Classification of chronic dystonia is linked to etiology ( Tables 40.7 and 40.8 ).
Primary pure dystonia: Dystonia is the only clinical symptom and there is no identifiable exogenous cause or other inherited degenerative disease.
Primary dystonia plus syndromes: Dystonia may be a prominent or early sign but there are other abnormal movements such as myoclonus, ataxia, or parkinsonism, and there is no evidence of neurodegeneration.
Primary paroxysmal dystonia: Dystonia occurs in brief episodes with normalcy in between. These disorders can be familial or sporadic.
Secondary dystonia: Dystonia is a symptom of an identified neurologic condition such as brain tumor, stroke, infection, inflammation, drugs, or toxins.
Heredodegenerative: Dystonia is one of many other neurologic signs or symptoms of a heredodegenerative or metabolic disorder (see Table 40.8 ).
Primary (Pure) Dystonia Autosomal Dominant
Autosomal Recessive
Primary Dystonia Plus Syndromes
Autosomal Recessive
Primary Paroxysmal Dystonia
Secondary Dystonia
|
Disorder | MOI | Gene(s) | Clues to the Diagnosis |
---|---|---|---|
Neurodegenerative Diseases | |||
DRPLA (dentatorubral-pallidoluysian atrophy) | AD | ATN1 | Huntington disease–like; prominent myoclonus |
Huntington disease (Westphal variant juvenile- or childhood-onset HD) | AD | HTT | Family history; caudate atrophy on MRI |
Huntington disease–like 2 | AD | JPH3 | African ancestry |
Rett or Rett-like syndrome | XL, AD | MECP2, FOXG1, GNB1 | Unusual stereotypies; autism |
Parkin type of early-onset Parkinson disease | AR | PARK2 | Abnormal DaTscan |
Chorea-acanthocytosis | AR (and possible AD) | VPS13A | Acanthocytes in blood smear |
McLeod neuroacanthocytosis syndrome | XL | XK | Weak expression of Kell antigens; acanthocytes in blood smear |
Neuronal intranuclear inclusion disease | AD or sporadic | Unknown | MRI: high-intensity signal in cortico-medullary junction on DWI images; intranuclear inclusions on skin biopsies |
Disorders Leading to Brain Calcification | |||
Primary familial brain calcification | AD | PDGFB , PDGFRB , SLC20A2, XPR1 | MRI/CT: calcifications in basal ganglia, white matter, and cerebellum |
Disorders of Heavy Metal Metabolism | |||
Wilson disease | AR | ATP7B | ↓ Plasma ceruloplasmin; Kaiser-Fleischer corneal ring; face of the giant panda sign on MRI |
Hypermanganesemia with dystonia, polycythemia, and cirrhosis | AR | SLC30A10 | T1-weighted hyperintensities in basal ganglia and cerebellum on MRI |
AR | SLC39A14 | ||
Neurodegeneration with Brain Iron Accumulation (NBIA) | |||
Mitochondrial membrane protein-associated neurodegeneration | AR | C19orf12 | T2-weighted hypointensities in substantia nigra and globus pallidus on MRI; T2-weighted hyperintense streaking between hypointense internal globus pallidus and external globus pallidus |
Aceruloplasminemia | AR | CP | MRI: hypointensity of basal ganglia, thalamus, red nucleus, occipital cortex, and cerebellar dentate nuclei on T2-weighted images |
Woodhouse-Sakati syndrome | AR | DCAF17 | Dystonia deafness syndrome; hypogonadism; alopecia |
Fatty acid hydroxylase–associated neurodegeneration | AR | FA2H | MRI: hypointensity of the globus pallidus, confluent hyperintensities of white matter on T2-weighted images, pontocerebellar atrophy, thin corpus callosum |
Neuroferritinopathy | AD | FTL | MRI: cystic lesions in the basal ganglia, bilateral pallidal necrosis; hypointensity of caudate, globus pallidus, putamen, substantia nigra, and red nuclei on T2-weighted images |
Pantothenate kinase–associated neurodegeneration | AR | PANK2 | Eye-of-the-tiger sign on MRI |
PLA2G6 -associated neurodegeneration | AR | PLA2G6 | Cerebellar hypoplasia and T2-weighted high signal in the cerebellum on MRI |
β-Propeller protein–associated neurodegeneration | XL | WDR45 | MRI: hypointense globus pallidus and substantia nigra on T2-weighted images |
Lipid Storage Disorders | |||
Neuronal ceroid-lipofuscinoses | AR; adult-onset AD or AR | ATP13A2 , CLN3 , CLN5 , CLN6 , CLN8 , CTSD , CTSF , DNAJC5 , GRN , KCTD7, MFSD8 , PPT1 , TPP1 | Dementia; epilepsy; visual loss in children |
Fucosidosis | AR | FUCA1 | MRI: hypointensity of globus pallidus and substantia nigra on T2-weighted images; dysostosis multiplex |
Niemann-Pick disease type C | AR | NPC1 , NPC2 | Supranuclear gaze palsy, splenomegaly, ↑ oxysterol blood levels |
Sphingolipidosis | |||
Arylsulfatase A deficiency | AR | ARSA | Progressive demyelination |
Lysosomal Storage Diseases | |||
Krabbe disease | AR | GALC | Progressive demyelination, enlargement of optic nerve and chiasm |
GM1-gangliosidosis | AR | GLB1 | MRI: hyperintensity of caudate nucleus and putamen with signs of diffuse hypomyelination on T2-weighted images |
GM2-gangliosidosis, AB variant | AR | GM2A | Indistinguishable from GM1-gangliosidosis |
Leukodystrophies | |||
Creatine deficiency syndromes | GAMT , GATM, SLC6A8 | MR spectroscopy: no creatine peak | |
Pelizaeus-Merzbacher disease | XL | PLP1 | Hypomyelination on MRI |
Disorders of Purine Metabolism | |||
Lesch-Nyhan syndrome | XL | HPRT1 | Self-mutilation; ↑ uric acid in plasma and urine |
Mitochondrial Disorders | |||
Leigh syndrome | AR, mt | Pathogenic variants in the mtDNA; nuclear genes ∗ | Bilateral basal ganglia lesions on MRI; ↑ lactate levels on magnetic resonance spectroscopy |
Leber hereditary optic neuropathy | Mt | Pathogenic variants in the mtDNA | Optic nerve changes on fundoscopy |
MELAS (mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes) | Mt | Pathogenic variants in the mtDNA | Deep white matter changes and strokelike lesions on MRI |
MERRF (myoclonus epilepsy associated with ragged-red fibers) | Mt | Pathogenic variants in the mtDNA | Progressive myoclonus, epilepsy, and ataxia; muscle biopsy showing ragged-red fibers; ↑ lactate in serum and CSF |
POLG -related disorders | AR, AD | POLG | Progressive external ophthalmoplegia, ataxia |
Deafness-dystonia-optic neuronopathy syndrome (Mohr-Tranebjaerg syndrome) | XL | TIMM8A | Dystonia (particularly oromandibular) and deafness |
Other dystonia-deafness syndromes | AD | SERAC1, SUCLA2 | Dystonia and deafness |
XL | DDP | Dystonia and deafness | |
Organic Acidurias | |||
D-2-hydroxyglutaric aciduria | AR | D2HGDH | Newborn screening |
Glutaric aciduria type 1 | AR | GCDH | Newborn screening |
Methylmalonic acidemia | AR | MCEE , MMAA , MMAB , MMADHC, MMUT | Newborn screening |
Aminoacidurias | |||
Homocystinuria caused by cystathionine β-synthase deficiency | AR | CBS | Homocysteine levels ↑ in blood |
Phenylketonuria | AR | PAH | Newborn screening |
Hartnup disorder | AR | SLC6A19 | Levels of neutral amino acids ↑ in urine |
Disorders of Biotin Metabolism | |||
Biotinidase deficiency | AR | BTD | Newborn screening |
Disorders of Thiamine Metabolism | |||
Biotin-thiamine-responsive basal ganglia disease | AR | SLC19A3 | Recurrent subacute encephalopathy; symmetric and bilateral edematous lesions in caudate nucleus, putamen, and cortex on MRI |
Disorders of Galactose Metabolism | |||
Classic galactosemia and clinical variant galactosemia | AR | GALT | Newborn screening |
Encephalopathy with Uncertain Pathogenesis | |||
Aicardi-Goutières syndrome | AD, AR | ADAR , RNASEH2A , RNASEH2B , RNASEH2C , SAMHD1 , TREX1 | Early-onset encephalopathy; chilblain lesions |
Disorders with ataxia as a predominant feature, particularly AD SCA (e.g., SCA3) and AR early-onset ataxias (e.g., ataxia-telangiectasia) |
∗ Genes associated with mitochondrial DNA-associated Leigh syndrome and NARP: BCS1L, C20ORF7, C8ORF38, COX10, COX15, FOXRED1, MTFMT, NDUFA2, NDUFA9, NDUFA10, NDUFA12, NDUFAF2, NDUFAF6, NDUFS1, NDUFS3, NDUFS4, NDUFS7, NDUFS8, SDHA, SURF1 .
Early-onset idiopathic torsion dystonia caused by variants in DYTI ( TOR1A /torsin A) represents the most common and most severe form of pure primary chronic dystonia in childhood. Previously referred to as dystonia musculorum deformans, it accounts for 16–53% of pediatric-onset dystonia in the non-Jewish population and for 80–90% of cases in the Ashkenazi Jewish population. The dystonia usually begins in childhood or early adolescence as a focal dystonia either in the hand or foot and gradually progresses. Rarely the neck or facial muscles may be involved first. Treatment is symptomatic.
This group of disorders with onset in childhood, adolescence, or early adulthood presents with dystonia with dramatic and sustained response to levodopa. This condition was initially referred to as dopa-responsive dystonia (DRD) with marked diurnal fluctuation or Segawa syndrome. Symptoms have marked diurnal fluctuation, with mild or minimal dystonia in the morning (after overnight sleep), progressively worsening toward the end of the day. Several clinically similar conditions with dystonia have been described, all with the common features of diurnal variation and responsiveness to levodopa. The collective group of DRD appears to be a fairly heterogenous group with either a dominant or recessive pattern of inheritance. Although most cases of DRD in childhood are due to pathogenic variants in guanosine triphosphate (GTP) cyclohydrolase 1 (GCH1) , other abnormalities such as compound heterozygous variants in GCH1, tyrosine hydroxylase (TH) , sepiapterin reductase (SPR) , or 6-pyruvoyltetrahydropterin synthase (6-PTS) genes have been found. Older adolescents with symptoms of DRD have been linked to juvenile parkinsonism and Parkin gene variants. Not all clinical forms have an identified genotype. CSF neurotransmitter metabolites show abnormalities in the dopamine metabolites neopterin and biopterin.
The age of onset is around 6 years, often with dystonia of the foot as the first presenting symptom. This gradually progresses to generalized dystonia. However, onset can be as young as infancy with dystonia and rigidity. It is not uncommon for such young children to be misdiagnosed as having cerebral palsy. Treatment with levodopa results in a dramatic improvement. In a child with chronic dystonia without an identified etiology, a trial of levodopa should be considered.
Acute or subacute hemidystonia should alert the clinician of the possibility of a space-occupying lesion in the contralateral basal ganglia such as a tumor or a stroke.
Hemidystonia has been reported as a symptom of Rasmussen syndrome.
Dystonia has also been reported as an early symptom of ataxia-telangiectasia occurring prior to the onset of ataxia.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here